• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.23% Nasdaq Down0.63%

    Alseres Pharmaceuticals, Inc. (ALSE)

    -Other OTC
    54.00 0.00(0.00%) Dec 31
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
    Total Revenue 18   18   418   18  
    Cost of Revenue -   -   -   -  
    Gross Profit 18   18   418   18  
    Operating Expenses
    Research Development -   -   -   -  
    Selling General and Administrative336  349  318  315  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (317) (331) 100   (296)
    Income from Continuing Operations
    Total Other Income/Expenses Net -   -  256  49  
    Earnings Before Interest And Taxes(317)(331)356  (247)
    Interest Expense4  1  117  115  
    Income Before Tax(321)(332)239  (363)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(321)(332)239  (363)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (321) (332) 239   (363)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (321) (332) 239   (363)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.